Electrovaya ELVA Q1 2026 Beat Revenue NA EPS Exceeds by Significant NeuroSense Therapeutics NRSN Q2 2025 Earnings Beat Revenue NA EPS 019 Market Analysts Assess Caterpillars LongTerm Growth Trajectory Galiano Gold GAU Q1 2026 Results Fall Short EPS 011 Revenue NA